Nilotinib d-tartrate 150 MG Oral Capsule — RxCUI 2715469
RxNorm drug concept · Semantic clinical drug
RxCUI 2715469
Semantic clinical drug · SCD
● Current RxNorm concept 6 FDA products
9 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2715469
Official nameNilotinib d-tartrate 150 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asnilotinib 150 MG (as nilotinib d-tartrate 192.517 MG) Oral Capsule
FDA products mapped6
Package NDCs mapped9
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Nilotinib: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
📖 Read our full Nilotinib guide →
🕸️ Concept Web — How Nilotinib d-tartrate 150 MG Oral Capsule Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Nilotinib d-tartrate 150 MG Oral Capsule
RxCUI 2715469 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Nilotinib
662281IN -
Nilotinib d-tartrate
2715454PIN
-
Nilotinib
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Nilotinib Oral Capsule
746605SCDF -
Nilotinib d-tartrate Oral Capsule
2715458SCDFP -
Nilotinib Oral Product
1158944SCDG -
Nilotinib Pill
1158945SCDG -
Nilotinib d-tartrate Oral Product
2715456SCDGP -
Nilotinib d-tartrate Pill
2715457SCDGP -
Oral Capsule
316965DF -
Oral Product
1151131DFG - +1 more in this family
-
Nilotinib Oral Capsule
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Nilotinib d-tartrate 150 MG
2715468SCDC
-
Nilotinib d-tartrate 150 MG
Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Nilotinib d-tartrate 150 MG
SCDC · 2715468 -
Nilotinib Oral Capsule
SCDF · 746605 -
Nilotinib d-tartrate Oral Capsule
SCDFP · 2715458 -
Nilotinib Oral Product
SCDG · 1158944 -
Nilotinib Pill
SCDG · 1158945 -
Nilotinib d-tartrate Oral Product
SCDGP · 2715456 -
Nilotinib d-tartrate Pill
SCDGP · 2715457
📦 FDA Products & Package NDCs
6 products · 9 package NDCs
9 package NDCs map to RxCUI 2715469 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 69097-0030-08 | 120 CAPSULE in 1 BOTTLE, PLASTIC (69097-030-08) | Nilotinib | Cipla USA Inc. | 2025-06-18 |
| 69097-0030-63 | 7 BLISTER PACK in 1 CARTON (69097-030-63) / 4 CAPSULE in 1... | Nilotinib | Cipla USA Inc. | 2025-06-18 |
| 69097-0031-74 | 4 CARTON in 1 CARTON (69097-031-74) / 4 BLISTER PACK in 1 C... | Nilotinib | Cipla USA Inc. | 2025-06-18 |
| 69097-0031-91 | 4 CARTON in 1 CARTON (69097-031-91) / 2 BLISTER PACK in 1 C... | Nilotinib | Cipla USA Inc. | 2025-06-18 |
| 69097-0032-74 | 4 CARTON in 1 CARTON (69097-032-74) / 4 BLISTER PACK in 1 C... | Nilotinib | Cipla USA Inc. | 2025-06-18 |
| 69097-0032-91 | 4 CARTON in 1 CARTON (69097-032-91) / 2 BLISTER PACK in 1 C... | Nilotinib | Cipla USA Inc. | 2025-06-18 |
| 76282-0788-12 | 120 CAPSULE in 1 BOTTLE, PLASTIC (76282-788-12) | Nilotinib | EXELAN PHARMACEUTICALS INC. | 2025-11-14 |
| 76282-0789-58 | 4 CARTON in 1 CARTON (76282-789-58) / 4 BLISTER PACK in 1 C... | Nilotinib | EXELAN PHARMACEUTICALS INC. | 2025-11-14 |
| 76282-0790-58 | 4 CARTON in 1 CARTON (76282-790-58) / 4 BLISTER PACK in 1 C... | Nilotinib | EXELAN PHARMACEUTICALS INC. | 2025-11-14 |
Observed labelers:
Cipla USA Inc. (6) ·
EXELAN PHARMACEUTICALS INC. (3)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.